This slideshow reviews brentuximab vedotin (Adcetris), indicated for treatment of Hodgkin lymphoma (HL) after failure of autologous stem cell transplant ...
This slideshow reviews cabazitaxel (Jevtana), indicated, in combination with prednisone, for the treatment of hormone refractory metastatic prostate cancer in ...
This slideshow reviews Tbo-figrastim (Granix), indicated for reduction in the duration of severe neutropenia in patients with non-myeloid malignancies receiving ...
This slideshow reviews vemurafenib (Zelboraf), indicated for the treatment of unresectable or metastatic melanoma with BRAF V600E mutation.
This slideshow reviews ofatumumab (Arzerra), indicated for the treatment of patients with chronic lymphocytic leukemia (CLL) refractory to fludarabine and ...
This slideshow reviews vincristine, indicated for Hodgkin disease, Kaposi sarcoma, leukemia, neuroblastoma, non-Hodgkin lymphoma, rhabdomyosarcoma, and Wilms' tumor.
This slideshow reviews paclitaxel protein-bound particles (Abraxane), indicated for metastatic breast cancer, locally advanced or metastatic non-small cell lung cancer, ...
This slideshow reviews pazopanib, indicated for the treatment of advanced renal cell carcinoma and advanced soft tissue sarcoma.
This slideshow reviews azacitidine (Vidaza), Indicated for the treatment of French-American-British (FAB) myelodysplastic syndrome subtypes.
This slideshow examines bendamustine (Treanda), indicated for the treatment of chronic lymphocytic leukemia (CLL) and indolent B-cell non-Hodgkin lymphoma (NHL).
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|